Research Site

Sant Joan Despí 08970

2 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Diabetes Mellitus, Non-Insulin-Dependent, ER-Positive HER2-Negative Breast Cancer, Heart Failure, High Risk for Cardiovascular Event, Hyperkalemia, Ophthalmic Safety in Patients With Breast Cancer

Studies at this site

• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) — Running, not enrolling
• An Ophthalmic Safety Study in Patients With Breast Cancer — Running, not enrolling
• Tracking Treatment Pathways in Adult Patients With Hyperkalemia. — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed